Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches?
Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
TD Cowen Maintains Buy on Elanco Animal Health, Raises Price Target to $32
Elanco Animal Health Intends To Form Elanco Ventures
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Elanco Animal Health Receives USDA Approval Of Its TruCan Ultra Lyme-L4 Combination Vaccine
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its Strong 1 Year Rally?
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
Elanco Animal Health Reaffirms Commitment To Providing Livestock Producers And Pet Owners With Resources, Treatment Options For Animals Against New World Screwworm
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
A Look At Elanco (ELAN) Valuation After Early Befrena Launch And Renewed Investor Optimism
Elanco (ELAN) Is Up 9.8% After Launching Befrena, Its Second USDA-Approved Pet Biologic
Elanco Animal Health Incorporated (ELAN) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.